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Abstract
The use of synthetic mRNA as an alternative gene delivery vector to traditional DNA-based constructs provides an effective
method for inducing transient gene expression in cell cultures without genetic modification. Delivery of mRNA has been
proposed as a safer alternative to viral vectors in the induction of pluripotent cells for regenerative therapies. Although
mRNA transfection of fibroblasts, dendritic and embryonic stem cells has been described, mRNA delivery to neurosphere
cultures has not been previously reported. Here we sought to establish an efficient method for delivering mRNA to primary
neurosphere cultures. Neurospheres derived from the subventricular zone of adult mice or from human embryonic stem
cells were transfected with EGFP mRNA by lipofection and electroporation. Transfection efficiency and expression levels
were monitored by flow cytometry. Cell survival following transfection was examined using live cell counting and the MTT
assay. Both lipofection and electroporation provided high efficiency transfection of neurospheres. In comparison with
lipofection, electroporation resulted in increased transfection efficiencies, but lower expression per cell and shorter
durations of expression. Additional rounds of lipofection renewed EGFP expression in neurospheres, suggesting this
method may be suitable for reprogramming applications. In summary, we have developed a protocol for achieving high
efficiency transfection rates in mouse and human neurosphere cell culture that can be applied for future studies of gene
function studies in neural stem cells, such as defining efficient differentiation protocols for glial and neuronal linages.
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Introduction
The mammalian nervous system contains populations of
multipotent stem cells that support ongoing requirements for
neurogenesis in the adult brain [1]. Adult neural stem cells can be
cultured in vitro as floating cell clusters known as neurospheres [2–
4]. In situ, NSCs supply progenitors that differentiate into specific
neuronal subtypes, depending on their anatomical location.
However, neurosphere cultures have been shown to display a
high degree of plasticity in their differentiation potential [5–8]. In
addition to the subventricular zone of the brain, human neuro-
sphere cultures can be established from more accessible neural
tissues, such as the olfactory epithelium [9], or from mesenchymal
and neural crest-derived stem cells in other tissues, including
muscle [10], adipose [11], bone marrow [12] and the ocular
limbus [13].
In recent years, cellular reprogramming techniques have been
developed for the induction of pluripotency in human primary
fibroblast cultures through the forced expression of a cocktail of
transcription factors, including OCT4, SOX2, C-MYC and KLF4
[14]. Since neurosphere cultures express SOX2 and C-MYC, they
may require fewer reprogramming factors [15], or be induced to
pluripotency through culture methods alone [16,17]. These
features make neurospheres an attractive candidate as a donor
cell for regenerative applications such as cellular reprogramming
and tissue engineering.
Cellular reprogramming methods rely on the ability to induce
and sustain ectopic gene expression in the donor cells, either
through the use of virus-mediated gene transfer [18,19] or non-
viral transfection of DNA vectors [20]. Viral gene delivery
methods are undesirable if reprogramming techniques are to be
used for clinical applications and transfected DNA can cause
mutations through random genomic integration or continue to
express genes after reprogramming is completed. For clinical
applications mRNA transfection has been proposed as an
alternative to DNA-based vectors for inducing gene expression
in cell cultures [21]. The mRNA vector provides a method of
inducing gene expression without lasting genetic modification of
the cell, making it the safest choice for clinical reprogramming
applications.
Efficient methods have been described for the delivery of
mRNA to human fibroblast cultures [22] as well as dendritic cells
[23] and embryonic stem cells [24]. However there are currently
no published methods describing the transfection of neurosphere
cultures. Here we demonstrate high efficiency mRNA delivery to
neurosphere cultures by lipofection and electroporation.
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Materials and Methods
Ethics Statement
C57BL/6 mice used in this study were bred at the Animal
Resources Centre (Murdoch University, WA) and maintained on a
12-hour day/night cycles, with free access to food and water.
Principles of laboratory animal care (NIH publication no. 85-23)
were followed at all times. All procedures conformed to the
Association for Research in Vision and Ophthalmology Statement
for the Use of Animals in Ophthalmic and Vision Research and
were approved by The University of Western Australia Animal
Ethics Committees (Permit No. RA/3/100/853).
Neurosphere Culture
Tissue was dissected from the subventricular zone of adult
C57BL/6 mouse brains as previously described [25]. For routine
passaging and culture, neurospheres were grown using the
StemPro Neural Stem Cell Serum-Free Media Kit according to
the manufacturer’s recommendations (Life Technologies, Carls-
bad, CA, USA).
mRNA Synthesis
Preparation of template DNA. Template DNA for in vitro
transcription was constructed by two-stage PCR and molecular
cloning. In the first stage an EGFP DNA fragment was amplified
by PCR from plasmid pEGFP-N1 (Clontech, Mountain View,
CA, USA) using the following primers: EGFP-fwd: 59- TAATAC-
GACTCACTATAGGATGGTGAGCAAGGGCGAGGAGC;
EGFP-rev: 59- GCCTCCCTCGCGTTATCAGAgATCTA-
gAgTCgCggCCgCTTTAC. First stage PCR produced a product
containing a T7 promoter at the 59 end, and an adaptor sequence
at the 39 end for addition of a polyA-tail. In the second PCR stage,
a polyT-tail was added to the 39end of the EGFP cDNA using the
EGFP-fwd primer the PolyT-rev primer (59-GCCTC-
CCTCGCGTTATCAGA-(T)130). After purification using the
PCR Purification Kit (Promega, Fitchburg, WI, USA), the PCR
product was cloned into pGEM-T Easy vector (Promega). The
resulting pGEMT-EGFP plasmid was transformed into JM109
competent E. coli cells (Promega) and purified using the Qiagen
Plasmid Maxi Kit (Qiagen, Venlo, The Netherlands). To prepare
template DNA for in vitro transcription (IVT), pGEMT-EGFP
DNA was linearized using ZraI (Promega) and purified by PCR
Cleanup Column (Promega). In vitro transcription. Capped
single stranded RNA was synthesized via IVT using the MEGA-
script-T7 kit (Life Technologies). Generally, 0.8 mg–1mg of purified
linear DNA was used in a 20 ml reaction. To obtain a high
proportion of capped transcripts, a 4:1 ratio of 3’-O-Me-
m7G(5’)ppp(5’)G RNA Cap Structure Analog (New England
BioLabs, MA, USA):GTP was used in RNA IVT reactions.
Reactions were incubated 3-4 hours at 37uC then treated with
1 ml TURBO DNase (Life Technologies) for a further 15-minutes
at 37uC before purification on RNeasy MiniSpin columns
(Qiagen). RNA products were eluted with 85 ml of H2O in each
column. To remove 59 triphosphate moieties from uncapped
transcripts, 10 ml of Antarctic Phosphatase reaction buffer and 5 ml
(25U) of Antarctic Phosphatase (New England BioLabs) was added
to each RNA product and incubated for 30-minutes at 37uC.
Synthesized RNA products were then repurified using RNeasy
Mini Columns (Qiagen) and quantitated by spectrophotometry
and denaturing gel electrophoresis. RNA products were examined
by electrophoresis on 2% agarose gels.
Lipofection
For lipofection experiments, neurospheres were transfected with
either Lipofectamine-2000 (LF2000, Life Technologies) or Tran-
sIT (Mirus Bio LLC, WI, USA). For each reagent, mRNA:lipid
ratios were optimized according to the manufacturers recommen-
dations. For both LF2000 and TransIT, an mRNA:lipid ratio of
1:3 was found to be optimal (data not shown). For routine
lipofection, whole neurospheres were collected from culture flasks
3–4 days after passaging. A sample of the neurosphere suspension
was trypisinzed and cell counts performed to determine the cell
concentrations. Whole neurospheres were plated at densities of 30
000 cells/well and 100 000 cells/well in 96 and 24 well plates,
respectively, and lipoplexes were added on the day of plating. For
transfection of adherent cultures, neurospheres were dissociated
with TrypLE-Express (Life Technologies) and plated on geltrex
(Life Technologies) coated plates at a density of 150,000 cells/cm2.
EGFP expression in transfected neurospheres was examined using
the Olympus IX70 inverted fluorescence microscope and imaged
using Olympus DP-Controller 3.1.1.267 acquisition software
(Olympus Corporation, Tokyo, Japan). For quantitation of
transfection efficiency and fluorescence per cell, neurospheres
were trypsinized and analyzed on the FACSCalibur flow
cytometer (Becton-Dickinson Biosciences, Franklin Lakes, NJ,
USA) as previously described [24]. Flow cytometry data was
analyzed using the WinMDI software (Joseph Trotter).
NEON Electroporation
For electroporation experiments, neurospheres were transfected
using the NEON microporation system (Life Technologies).
Neurospheres were dissociated using TrypLE Express (Life
Technologies) after 3–4 days of growth and resuspended at high
cell density in Electroporation Buffer-T. Electroporations were
performed in a 10 ml tip containing 100 000 cells and 500ng-2 mg
of mRNA. Immediately following electroporation, neurosphere
cells were plated into one well in a 24-well plate. Under these
conditions, neurospheres were rapidly formed by reaggregation of
single cells. Electroporations were optimized using a range of
settings according to the manufacturers recommendations. Opti-
mal electroporation results were achieved using a single 20ms
pulse at 1350V. Higher voltages were found to induce high levels
of cell death (data not shown).
MTT Cell Proliferation Assay
Neurosphere growth was measured using the MTT (3- [4,5-
dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) assay
(Sigma, St. Louis, MO, USA) as previously described [25].
Neurospheres were dissociated by trituration in PBS, seeded into
96-well plates at a density of 30000 cells/well and cultured
overnight to allow sphere formation by cell aggregation. Three
days after transfection, 10 ml MTT (Sigma, St. Louis, MI, USA)
solution (2.5 mg/ml) was added to each well and plates were
incubated at 37uC to allow mitochondrial uptake. After 2 hours,
cells were lysed by the addition of an equal volume of acidified
isopropanol and the absorbance measured at 590nm using the
Beckman-Coulter AD200 spectrophotometer (Beckman-Coulter,
Brea CA, USA). Within each experiment, absorbances were
averaged across 3–6 replicate wells.
Differentiation Assay
For differentiation experiments, transfected and control neuro-
spheres were plated onto poly-ornithine/laminin coated chamber
slides (Becton Dickinson Biosciences, Franklin Lakes, NJ, USA) in
StemPro Neural Stem Cell Serum-Free Media (Life Technologies).
mRNA Transfection of Neurosphere Cultures
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Figure 1. Transfection of Mouse Neurospheres with EGFP mRNA. A: Adult mouse neurospheres were transfected in 24 well plates with
500ng of EGFP mRNA using the lipofection reagents Lipofectamine 2000 or Transit or with 1 mg of EGFP mRNA using the NEON microporation
system. Transfection efficiency (left panel) and EGFP fluorescence per cell (right panel) were measured by flow cytometry. 24 hours after transfection.
B: Mouse neurospheres were cultured as either adherent monolayers (dashed line) or floating neurospheres (solid line) in 24 well plates and
transfected with increasing amounts of EGFP mRNA lipoplexes. Transfection efficiency (left panel) and EGFP fluorescence per cell (right panel) were
measured by flow cytometry. C: Whole mouse (solid line) or human (dashed line) neurospheres were transfected with increasing concentrations of
mRNA using the NEON microporation system and seeded into 24 well plates. Transfection efficiency (%EGFP, dashed line) and EGFP fluorescence per
cell (MPF, solid line) were measured by flow cytometry. D: Mouse neurospheres were transfected with 500ng of EGFP mRNA lipoplexes (solid line),
pEGFP-N1 DNA lipoplexes (dotted line) or 1 mg of EGFP mRNA using the NEON microporator (dashed line). Transfection efficiency (left panel) and
EGFP fluorescence per cell (right panel) were measured by flow cytometry 24, 48, 72 and 120 hours after transfection.
doi:10.1371/journal.pone.0083596.g001
mRNA Transfection of Neurosphere Cultures
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After overnight culture, the media was replaced without EGF and
FGF-2. Slides were fixed for 15 minutes at 37uC in 4%
paraformaldehyde 1, 3 and 5 days after plating. Fixed chamber
slides were bathed in cold (–20uC) methanol for 15 min at room
temperature then washed with PBS. Blocking solution (PBS + 5%
normal goat serum + 0.3% Triton) was added and slides incubated
at room temperature for 45 min. Primary antibodies were diluted
to working concentrations in blocking solution, added to slide
chambers and incubated at room temperature for 1 hour. The
slides were then washed three times in PBS before the incubation
with secondary antibodies and the nuclear marker 4,6-diamidino-
2-phenylindole (DAPI). After 1-hour at room temperature, slides
were washed and mounted in fluorescent mounting media (Dako,
Glostrup, Denmark). Antibodies (and working concentrations)
used in these studies were as follows: rabbit anti-Ki67 (1:500,
Abcam), mouse anti-bIII-Tubulin (1:500, Promega), rabbit anti-
Nestin (1:250, Abcam), rabbit anti-GFAP (1:500, Dako), goat anti-
mouse IgG-AlexaFluor594 (1:500, Life Technologies) goat
anti-rabbit-IgG-AlexaFluor488 (1:500, Life Technologies) and
goat anti-rabbit-IgG-AlexaFluor594 (1:500, Life Technologies).
RT-PCR Analysis
Total RNA was extracted from neurospheres using the AllPrep
RNA/Protein Kit (Qiagen). Total RNA was then quantified using
the Nanodrop 2000 spectrophotometer (ThermoFisher Scientific,
Waltham, MA, USA). First-strand cDNA was synthesized using 1–
3 mg of RNA and SuperScript III Reverse Transcriptase (Life
Technologies) according to the supplier’s protocol. RT-PCR
reactions for mouse IFNb and GAPDH were performed in a 10 ml
mixture containing 1 ml (50–100 ng) of cDNA, primers (10 mM)
and Rotor-Gene SYBR-Green RT-PCR Master Mix (Qiagen) in
the 9600 GeneAmp PCR thermocycler (Perkin Elmer, Waltham,
MA, USA). RT-PCR reactions were examined by gel electropho-
resis on 1% agarose. Primer sequences used were: Mouse IFNb:
Fwd 59-GGAGATGACGGAGAAGATGC, Rev 59-CCCAG-
TGCTGGAGAAATTGT; Mouse GAPDH: Fwd 59-GGT-
Figure 2. Lipofection of EGFP mRNA in Mouse Neurospheres. A: Adult mouse neurospheres were cultured in 96 well plates and transfected
with increasing concentrations of mRNA lipoplexes using Lipofectamine 2000 or TransIT. Two days after transfection, cell numbers were quantitated
using the MTT assay. B: Mouse neurospheres were plated onto geltrex-coated 24 well plates 24 hours after transfection with 500ng of mRNA
lipoplexes. After overnight culture, resulting monolayers were fixed and the proportion of proliferating cells determined by Ki67 immunostaining.
Each bar represents the mean percentage of Ki67+ cells from 6-8 transfections. Error bars indicate standard deviation. C: Transfected mouse
neurospheres were plated as described in B and immunostained for Ki67, Nestin or bIII-Tubulin. Micrographs show merged images consisting of the
antibody signal (red), EGFP fluorescence (green). Scale bars indicate 50 mm. D:Mouse neurospheres were transfected with 500ng of mRNA lipoplexes,
plated onto geltrex and cultured without mitogens for 3 days before immunostaining for bIII-Tubulin (red) and DAPI (blue). Scale bar indicates 50 mm.
E: Quantitation of neuronal cells. Each bar represents the mean percentages of bIII-Tubulin+ cells from 3 transfections. Error bars indicate standard
deviation.
doi:10.1371/journal.pone.0083596.g002
mRNA Transfection of Neurosphere Cultures
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GAAGGTCGGTGTGAACG, Rev 59-CTCGCTCCTGGAA-
GATGGTG.
Cell Cycle Analysis
Cell cycle analysis was performed as previously described [26].
Neurospheres were harvested and dissociated into single cells by
brief incubation in TrypLE Express (Life Technologies). Cells
were then added dropwise into another tube containing ice-cold
100% ethanol mixing on a vortex, and incubated on ice for 10
minutes. Ethanol was then removed and cells were resuspended in
ice-cold phosphate buffered saline (PBS) containing 2% fetal calf
serum, RNase1 (100 mg/ml), and propidium iodide (PI, 50 mg/
ml). DNA analysis was then performed using FACSCalibur flow
cytometer (Becton-Dickinson Biosciences).
Results and Discussion
To select a method for mRNA delivery, mouse neurospheres
were transfected with EGFP-mRNA prepared by in vitro
transcription using a lipofection system (LipofectAMINE-2000
(LF2000) or TransIT), or the NEON microporation system. EGFP
expression was measured by flow cytometry after 24-hours.
Lipofection of neurospheres typically yielded transfection efficien-
cies of up to 40–50%. In comparison, electroporation yielded
higher transfection efficiencies (60–70%), with lower EGFP
expression per cell (Figure 1a). Increasing the concentration of
mRNA lipoplexes during lipofection or free mRNA during
microporation did not increase transfection efficiency, but did
result in small increases in EGFP fluorescence per cell (Figure 1b-
c). Lipofection efficiencies were maximal at 50–100ng mRNA/
well in a 96-well plate, and at 500ng-1 mg mRNA/well in a 24-
well plate. (Figure 1b and data not shown). Electroporation
efficiency was optimal using 1 mg of mRNA per 100000 neuro-
spheres cells (Figure 1c).
Since neurospheres grow as cell clusters in suspension,
accessibility of lipoplexes to the cells may become more restricted
as neurospheres get larger. Indeed, transfection efficiency was
increased in small neurospheres grown for 3 days in culture,
compared with large neurospheres grown for 7 days in culture
(50% vs 20%, data not shown). To increase lipoplex accessibility to
neural progenitor cells, neurospheres were plated onto extracel-
lular matrix and cultured as adherent monolayers. Higher
transfection efficiencies were achieved with lower mRNA lipoplex
concentrations in neurosphere monolayers (60%) compared with
whole neurospheres in suspension (40%). However, transfection
efficiency could not be further increased through addition of more
lipoplexes in either sphere cultures or adherent monolayers (Figure
1b). While, floating neurospheres tolerated additional lipoplexes,
adherent neurosphere monolayers showed signs of significant cell
death at mRNA lipoplex concentrations above 800ng/well in a
24-well plate (Figure 1b). Increasing mRNA concentration during
electroporation did not increase transfection efficiencies and a
population of cells (30–40%) failed to express EGFP (Figure 1c).
These results suggest that a population of neurosphere cells do not
Figure 3. Multiple Transfection of Mouse Neurospheres. A: Adult mouse neurospheres were cultured as whole NS in 24 well plates and
transfected with 500ng of EGFP mRNA lipoplexes. Two days after the first transfection, a second dose of lipoplexes was applied to the cultures.
Transfection efficiencies were measured by flow cytometry and fluorescence microscopy 72 hours after the first transfection. Flow cytometry plots
show neurospheres receiving no lipoplexes (left panel), a single dose (middle panel) or two doses (right panel) of mRNA lipoplexes. B: Total RNA was
extracted adult mouse neurospheres and IFNb expression measured by RT-PCR (lower bands) 24 hours after transfection. RT-PCR for GAPDH mRNA
(upper band) was performed as a positive control. Lanes in the left panel show untransfected control neurospheres (C-), neurospheres treated with
LF2000 alone (V-) or with EGFP mRNA lipoplexes (E-) after a single (24) or double (48) dose of lipoplexes. The right panel shows IFNb expression after
a single transfection of increasing amounts (0, 200ng, 500ng, 1 mg, 2 mg) of EGFP mRNA lipoplexes. The 1 kb Plus DNA Ladder (Life Technologies) is
shown in the first lane of each panel.
doi:10.1371/journal.pone.0083596.g003
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take up mRNA, as previously reported during mouse embryonic
stem cell transfection [24].
Following a single lipofection of EGFP mRNA, bright green
fluorescence was detected in approximately 50% of transfected
mouse neurosphere cells for around 48-hours, after which both the
number of EGFP expressing cells and the intensity of the signal
diminished (Figure 1d).
In comparison, lipofection of neurospheres with the pEGFP-N1
plasmid was less efficient than EGFP mRNA. Following DNA
transfection, transfection efficiencies increased over the 5-day time
course examined (Figure 1d). Despite lower transfection efficien-
cies, plasmid DNA yielded brighter EGFP fluorescence than
mRNA in transfected cells, suggesting strong activity of the CMV-
IE promoter in mouse neurosphere cells. 3-days after DNA
transfection EGFP expression per cell decreased by half, while
transfection efficiency continued to increase during this time,
suggesting the division of transfected cells and dilution of both
EGFP protein and transfected plasmid. After 5 days, EGFP levels
in DNA transfected neurosphere cells had recovered to maximal
levels indicating continued expression of EGFP from retained
plasmids (Figure 1d).
In contrast to DNA transfection, mRNA lipofection elicited a
transient wave of EGFP expression. Both transfection efficiency
and EGFP expression per cell reached their peak values at 24–
48 hours and dropped markedly at 72-hours (Figure 1d),
consistent with the degradation of the EGFP mRNA and protein.
Microporation resulted in lower levels of EGFP expression than
lipofection and a shorter duration of EGFP expression, with peak
transfection efficiencies observed 24-hours after electroporation
(Figure 1d).
LF2000 lipoplexes were well tolerated by mouse neurospheres
over a range of concentrations. 24-hours after lipofection,
neurospheres transfected with increasing concentrations of
LF2000-mRNA lipoplexes had similar numbers of viable cells as
untransfected controls. LF2000 lipoplexes were toxic only at very
high concentrations (600ng/well in a 96-well plate). In contrast,
mouse neurospheres displayed dose dependent toxicity when
exposed to lipoplexes formed using the TransIT reagent (Figure
2a).
To determine whether lipofection of mRNA affected prolifer-
ation or differentiation potential, mouse neurospheres were
transfected with EGFP mRNA before plating onto geltrex coated
chamber slides for monolayer culture. 24-hours after plating,
neurosphere monolayers were fixed and immunostained for the
neural progenitor marker Nestin or the proliferation marker Ki67.
Nestin immunolabelling was observed in the majority of cells and
was unaffected by EGFP-mRNA lipofection (data not shown).
Similar proportions of cells (20%) were immunopositive for Ki67
in transfected and control monolayers, indicating that lipofection
of EGFP-mRNA did not induce cell cycle exit (Figure 2b). EGFP
fluorescence was present in cells that were immunopositive for
Nestin, Ki67, bIII-tubulin (Figure 2c) or GFAP, suggesting
lipoplex uptake was not limited to or excluded by different
populations of progenitors within the neurosphere.
To induce differentiation, EGF and FGF2 were removed from
the culture media 24-hours after plating. 3-days after growth factor
Figure 4. mRNA Transfection of Human Neurospheres. A-D: Human embryonic stem cell-derived neurospheres were transfected using
LF2000 in suspension culture (A-B) or adherent monolayers (C) or using NEON electroporation (D) Micrographs were taken 24 hours after
transfection. Scale bars indicate 250 mm. E: Human neurospheres were transfected with 500 ng of EGFP mRNA lipoplexes in 24 well plates. Two days
after the first transfection, a second dose of lipoplexes was applied to the cultures. Transfection efficiencies were measured by flow cytometry and
fluorescence microscopy 72 hours after the first transfection. Flow cytometry plots show neurospheres receiving no lipoplexes (left panel), a single
dose (middle panel) or two doses (right panel) of mRNA lipoplexes. Insets in E show fluorescence micrographs of human neurospheres.
doi:10.1371/journal.pone.0083596.g004
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removal, transfected neurospheres yielded similar proportions of
bIII-tubulin expressing neurons as untransfected controls (Figure
2d-e). After five days, expression of GFAP in differentiating
cultures was also unaltered by transfection (data not shown).
Together, the above data demonstrate that LF2000 provides a
high efficiency, low toxicity method for mRNA lipofection of
neurosphere cultures that does not alter the proliferation or
differentiation of the transfected neural progenitors.
For cellular reprogramming applications, the persistence of
artificial DNA constructs in reprogrammed cells is disadvanta-
geous for a number of reasons, including incomplete silencing or
insertional mutagenesis of transgenes. The degradation of
transfected mRNA by endogenous pathways provides an elegant
Figure 5. Cyclin D1 enhances mouse neurosphere transfection. A: Adult mouse neurospheres were seeded as single cells and cultured for 3
or 6 days. Day 4 neurospheres and day 6 neurospheres were dissociated, fixed and stained with PI for cell cycle analysis by flow cytometry (black bars)
or were plated onto geltrex and stained for Ki67 (white bars). B: Mouse neurospheres were transfected with 500ng EGFP mRNA on day 4 or day 5
after seeding as single cells. Transfection efficiencies were measured by flow cytometry after 24 hours. C: Day 3 adult mouse neurospheres were
transfected with 500ng of CyclinD1 or mRNA lipoplexes (lower plot) or LF2000 alone (upper plot). 24 hours after transfection, cells were dissociated
and cell cycle profiles obtained by PI staining and flow cytometry. D: Day 6 mouse neurospheres were transfected with 1 mg of mRNA lipoplexes
containing either EGFP mRNA or EGFP mRNA plus Cyclin D1 mRNA (500ng each). Transfection efficiency was measured by flow cytometry 24 hours
later.
doi:10.1371/journal.pone.0083596.g005
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solution to these issues, enabling the induction of exogenous gene
expression without genetic modification of the cell. However, the
transience of the mRNA signal after lipofection also represents a
technical challenge for reprogramming applications, which require
sustained expression of transcription factors over longer periods of
time than can be achieved by a single lipofection. To overcome
this problem, mRNA reprogramming protocols incorporate
multiple transfections.
During suspension culture neurospheres are formed from single
cells over 3–7 days before reaching sizes of 200–400 mm and
requiring further passaging. Taking the growth and expression
kinetics into account, we opted for a double transfection protocol
to sustain expression over 4–5 days of neurosphere growth. Small
neurospheres (,100 mm) were transfected with EGFP-mRNA 3-
days after passaging, resulting in EGFP expression in 40–60% of
cells. As shown above, EGFP expression in single transfected wells
had declined markedly 72-hours after lipofection, however, the
application of a second dose of mRNA lipoplexes at 48-hours
restored the population of green fluorescent cells observed by flow
cytometry at 72-hours, indicating fresh uptake of mRNA
lipoplexes (Figure 3a).
Transfected mRNA can activate intracellular RNA-receptors,
inducing signal transduction and expression of type 1-interferon
(IFN) genes. In fibroblasts, activation of IFN receptors after
mRNA transfection primes cells for apoptosis on subsequent
transfection, limiting the efficacy of repeated transfection protocols
[27,28]. Using our multiple lipofection protocol, we observed the
induction of IFNb expression by RT-PCR in double transfected,
but not single transfected neurospheres (Figure 3b, left panel).
However, increasing the lipoplex concentration during a single
transfection resulted in a dose dependent increase in IFNb
expression. Low lipoplex concentrations (200 ng/well) resulted in
no IFNb mRNA detected, while concentrations above 500 ng/
well induced robust IFNb expression (Figure 3b, right panel). In
mouse neurospheres, IFNb has been shown to activate JAK-
STAT signaling, increase expression of the Cdk inhibitor p27 and
inhibit proliferation [26]. Therefore, additional experiments are
warranted to determine whether the use of modified mRNA [28]
or siRNA targeting molecules involved in IFN signaling [27] can
be applied to neurospheres to prevent IFNb induction.
In parallel experiments, human embryonic stem cell-derived
neurospheres (hENS) performed similarly to mouse neurospheres
when transfected with EGFP mRNA by lipofection or micropora-
tion (Figure 1c, 4a-d). In multiple transfection experiments, a
second application of mRNA lipoplexes 48-hours after transfection
could also be used to sustain EGFP expression in transfected
hENS neurospheres (Figure 4e).
In culture, neurospheres are formed from single cells that grow
into clusters of dividing progenitors and small populations of stem
cells. The initial logarithmic growth phase lasts for 4 days, with
neurospheres reaching maximum sizes within 5-6 days. Both Ki67
immunostaining and cell cycle analysis by flow cytometry revealed
a large reduction in the number of proliferating cells after 6 days of
mouse neurosphere growth compared with 4 days of neurosphere
growth (Figure 5a). We found mRNA lipofection efficiency was
similarly reduced in neurospheres cultured for 5 days compared
with neurospheres cultured for 4 days (Figure 5b). These results
suggest that lipoplex uptake by neurospheres may be dependent on
proliferation, as previously observed in other cell types [24].
To enhance proliferation in mouse neurospheres, we transfected
cells with Cyclin-D1 mRNA. 24 hours after transfection, neuro-
spheres were dissociated, fixed and stained with PI for cell cycle
analysis by flow cytometry. While 21% of cells treated with
LF2000 alone were found to be in S-M phase of the cell cycle,
transfection with Cyclin D1 mRNA increased the proportion of
actively dividing cells to 37% (Figure 5c).
To further explore the relationship between lipofection
efficiency and neurosphere growth, we transfected mouse neuro-
spheres with 1 mg of EGFP mRNA 6 days after seeding.
Transfection efficiency was only 8% in day 6 neurospheres,
consistent with the number of Ki67+ cells present at this time
(Figure 5a, d). However, transfection of day 6 mouse neuro-
spheres with lipoplexes containing 500ng of EGFP mRNA and
500ng of CyclinD1 mRNA increased EGFP transfection efficiency
to 20% (Figure 5d). Together, these results suggest CyclinD1
mRNA promoted cell division in transfected neural progenitor
cells.
The similarity in transfection kinetics between mouse and
human neurospheres could suggest a general applicability of these
methods to neurosphere cultures of diverse origin. Indeed,
neurospheres cultured from the adult human or mouse ocular
limbus could also be transfected using the methods described here
(data not shown). Since neurospheres may be easily derived from a
number of tissues that are accessible in adult human patients [9–
12], they may represent a useful source of autologous donor cells
for cellular reprogramming applications, including the induction
of pluripotent stem cell lines. The use of mRNA transfection for
inducing gene expression in neurospheres avoids any risks
associated with viral or DNA vectors, providing a method suitable
for clinical application. Our results demonstrate that multiple
doses of mRNA lipoplexes can be used to sustain gene expression
during neurosphere growth. Taken together, our findings suggest a
transfection regime consisting of 2–3 doses of 500-1 mg mRNA
lipoplexes with an mRNA:LF2000 ratio of 1:3 at 48-hour intervals
is suitable to sustain EGFP gene expression in mouse and human
neurospheres cultures.
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